OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

dusky dolphin - Sat, 30 Dec 06 :

Patrick Evershed. Forecast for 2007 Telegraph Money Section

'Top share will be Oxford Biomedica which could complete value enhancing deals during the year. First could be for it's lead cancer drug - Trovax. The second could be for it's Parkinson treatment which is reputed to have gone exceptionally well in pre-clinical trial, and the last is for it's LentiVector drup delivery system which is in demand from other pharmaceuticual companies.'

Happy and Prosperous New Year to all LTI

Oxford Biomed Stock Charts :

Oxford Biomed Historic Stock Chart

Oxford Biomed Intraday Stock Chart

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright©1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN

30 site:2us *** oxb080822 05:37 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )